News NICE lifts cost limit on drugs to improve access to end of life treatments BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b3 (Published 06 January 2009) Cite this as: BMJ 2009;338:b3 Article Related content Metrics Responses Peer review Related articles News NICE rules that drug used in advanced liver cancer is not cost effective for the NHS Published: 23 November 2009; BMJ 339 doi:10.1136/bmj.b4956 News Health department sets up cost sharing deal for multiple myeloma drug Published: 02 February 2009; BMJ 338 doi:10.1136/bmj.b423 News NICE recommends kidney cancer drug it previously rejected on cost grounds Published: 09 February 2009; BMJ 338 doi:10.1136/bmj.b499 See more The Association of Cancer Physicians responds to “Cancer drugs, survival, and ethics” BMJ December 05, 2016, 355 i6487; DOI: https://doi.org/10.1136/bmj.i6487 Voluntary euthanasia deaths in Quebec outstrip predictions by three to one BMJ November 23, 2016, 355 i6331; DOI: https://doi.org/10.1136/bmj.i6331 US transplant study may have violated federal rules BMJ November 04, 2016, 355 i5956; DOI: https://doi.org/10.1136/bmj.i5956 The Big Picture: Celebrating death BMJ November 02, 2016, 355 i5897; DOI: https://doi.org/10.1136/bmj.i5897 Royal colleges issue list of 40 unnecessary interventions BMJ October 26, 2016, 355 i5732; DOI: https://doi.org/10.1136/bmj.i5732
